Rinvoq is a prescription medication used to treat rheumatoid arthritis, psoriatic arthritis, atopic dermatitis (eczema), ulcerative colitis, Crohn’s disease, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. This medication is available as an oral long-acting (extended-release) tablet. Rinvoq can reduce the body’s ability to fight infections, increase the risk of certain cancers, increase the risk of cardiovascular events (such as heart attack or stroke), and cause blood clots.
Rinvoq
Rinvoq
Treats rheumatoid arthritis, psoriatic arthritis, atopic dermatitis (eczema), ulcerative colitis, Crohn’s disease, ankylosing spondylitis, and non-radiographic axial spondyloarthritis.
Disease-modifying antirheumatic, janus kinase (JAK) inhibitor
Long-acting tablet
By mouth
Rinvoq (upadacitinib) is a Janus kinase (JAK) inhibitor that blocks specific signals that are thought to cause inflammation. Rinvoq is used to treat certain inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, atopic dermatitis (eczema), ulcerative colitis, Crohn’s disease, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. This medication comes as an oral tablet that is long-acting (extended-release) and taken once a day.
You may be more likely to develop infections while taking Rinvoq. These infections are usually mild (such as a cold or a sinus infection), but occasionally, they can be serious or even life-threatening, so it is important to monitor infection symptoms.
Get early treatment for any infection so they don't become more serious. It is important to tell your doctor if you get symptoms of infection such as fever, tiredness, persistent cough, wounds, skin sores and blisters, dental problems, or burning on urination.
While taking Rinvoq, you should not receive some types of vaccinations. Discuss receiving vaccines with a healthcare provider.
Some cases of skin cancer have occurred in people taking Rinvoq, so it is important to check for new skin lesions and regularly check the whole body for changes in skin appearance.
While taking Rinvoq, there have been cases of blood clots in the veins called venous thrombosis. It’s important to tell your doctor right away if you have a painful swollen leg, chest pain, or shortness of breath.
Long-acting (24-hour extended-release) tablet
15 mg
30 mg
45 mg
The dose of Rinvoq will depend on the type of inflammatory condition being treated.
The typical standard dose of Rinvoq is a 15 mg tablet once daily.
When treating certain inflammatory conditions, some people may require a higher dose to treat the condition properly. If the Rinvoq standard dose of 15 mg is not effective enough, healthcare providers will increase the dose to a 30 mg tablet once daily.
Certain conditions require an induction period when starting Rinvoq. The typical induction dose of Rinvoq is a 45 mg tablet once daily for eight to twelve weeks depending on the condition.
Rinvoq
28 tablets extended release 24 hour bottle
Rinvoq
30 tablets extended release 24 hour bottle
Your doctor will tell you how much medicine to use. Do not use more than directed.
Take your medicine around the same time each day as it will help you remember when to take it.
This medication can be taken with or without food.
Swallow the extended-release tablet whole. Do not crush, break, or chew it.
If you take the extended-release tablet, part of the tablet may pass into your stools. If this happens, contact your healthcare provider as they’ll need to assess the treatment.
Avoid food or beverages containing grapefruit while taking Rinvoq as eating grapefruit or drinking grapefruit juice may increase the risk of side effects.
This medicine should come with a Medication Guide. Ask your pharmacist for a copy if you do not have one.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light.
Take a dose as soon as you remember, as long as it is at least ten hours before your next dose. Otherwise, skip the missed dose and wait until it is time to take a regular dose. Do not take extra medicine to make up for a missed dose.
This medicine is not right for everyone. Do not use it if you have an allergic reaction to upadacitinib.
Rinvoq is not safe to take during pregnancy as it can harm an unborn baby. Tell your doctor right away if you become pregnant. Use an effective form of birth control during treatment with this medicine and for at least 4 weeks after the last dose.
Do not breastfeed during treatment with this medicine and for at least 6 days after the last dose.
Tell your doctor if you have kidney disease, liver disease (including hepatitis B or C), blood problems, cancer or a history of cancer, diabetes, lung disease, HIV, stomach or bowel problems (including diverticulitis), or a history of tuberculosis. Also, tell your doctor if you have a current infection or an infection that keeps returning.
This medicine may cause the following problems: Increased risk for serious infections (bacterial, fungal, viral), including herpes infection or shingles. Increased risk for cancer, including non-melanoma skin cancer. Increased risk for blood clots, stomach or bowel perforation (tear or hole), or high cholesterol in the blood. Increased risk for heart attack or stroke.
You must have a skin test for tuberculosis (TB) before starting this medicine. Tell your doctor if you or anyone in your home has ever had a positive TB skin test or been exposed to TB.
This medication can reduce your body’s ability to fight infections. Rinvoq can make infections that you already have worse or increase the risk of new infections.
Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments.
Keep all medicine out of the reach of children. Never share your medicine with anyone.
Some medicines can affect how upadacitinib works. While there are many possible drug interactions, tell your doctor if you are using any of the following: atorvastatin, azathioprine,, carbamazepine, clarithromycin, cyclosporine, ethinyl estradiol, itraconazole, ketoconazole, levonorgestrel, methotrexate, midazolam, phenobarbital, phenytoin, posaconazole, rifampin, rosuvastatin, voriconazole, or NSAID pain medicine (including aspirin, diclofenac, ibuprofen, naproxen). There are many other possible Rinvoq drug interactions that are not included.
This medicine may interfere with vaccines. Ask your doctor before you get a flu shot or any other vaccine.
Rinvoq interacts with grapefruit, so it is best to avoid food or beverages containing grapefruit while taking Rinvoq. Grapefruit and grapefruit juice may increase the risk of side effects.
It’s important to tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Rinvoq can reduce the body’s ability to fight infections. It can make infections that you already have worse or increase the risk of new infections, which can be life-threatening. Contact your doctor immediately if you have signs of an infection.
Serious side effects
Allergic reaction: Itching or hives, swelling in your face or hands, swelling or tingling in your mouth or throat, chest tightness, trouble breathing
Chest pain, trouble breathing, weakness in one part or on one side of your body, slurred speech
Dark urine or pale stools, nausea, vomiting, loss of appetite, stomach pain, yellow skin or eyes
Fever, chills, cough, runny or stuffy nose, sore throat, night sweats, body aches
Pain, redness, swelling, or tenderness in the arms or legs, chest pain, or shortness of breath
Skin or mole changes, sores that do not heal
Unusual bleeding, bruising, or weakness
Less serious side effects
Acne
Inflammation of the hair follicles
Nausea, feeling sick in the stomach
Weight gain
It’s important to communicate with your doctor or pharmacist as soon as possible if you do not feel well while taking Rinvoq or if you have any problems taking it.
Rinvoq Prescribing Information, DailyMed
Rinvoq, Abbvie
Stephanie Melby, B.S., Pharm.D., received a bachelor of science in nutrition from the University of Minnesota and a doctorate of pharmacy from the University of New England. She has seven years of experience in retail pharmacy and is certified in Medication Therapy Management (MTM). Dr. Melby resides in Minneapolis, Minnesota.
...SingleCare es un servicio de descuentos para medicamentos recetados que ofrece cupones gratuitos para miles de medicamentos. Puedes usarlo aun si tienes seguro, Medicare, Medicaid o no, pero no se puede combinar con el seguro.
SingleCare ofrece transparencia al mostrar los precios de medicamentos para que puedas comparar descuentos en farmacias cerca de ti. Visita singlecare.com para encontrar descuentos en medicamentos, información útil sobre tu receta médica y recursos que te ayudan a tomar decisiones informadas sobre tu salud.
Los ahorros en recetas varían según la receta médica y la farmacia, y pueden alcanzar hasta un 80% de descuento sobre el precio en efectivo. Este es un plan de descuento de recetas médicas. NO es un seguro ni un plan de medicamentos de Medicare. El rango de descuentos para las recetas médicas que se brindan bajo este plan, dependerá de la receta y la farmacia donde se adquiera la receta y puede otorgarse hasta un 80% de descuento sobre el precio en efectivo. Usted es el único responsable de pagar sus recetas en la farmacia autorizada al momento que reciba el servicio, sin embargo, tendrá el derecho a un descuento por parte de la farmacia de acuerdo con el Programa de Tarifas de Descuento que negoció previamente. Towers Administrators LLC (que opera como “SingleCare Administrators”) es la organización autorizada del plan de descuento de recetas médicas ubicada en 4510 Cox Road, Suite 11, Glen Allen, VA 23060. SingleCare Services LLC (“SingleCare”) es la comercializadora del plan de descuento de prescripciones médicas que incluye su sitio web www.singlecare.com. Como información adicional se incluye una lista actualizada de farmacias participantes, así como también asistencia para cualquier problema relacionado con este plan de descuento de prescripciones médicas, comunícate de forma gratuita con el Servicio de Atención al Cliente al 844-234-3057, las 24 horas, los 7 días de la semana (excepto los días festivos). Al utilizar la aplicación o la tarjeta de descuento para recetas médicas de SingleCare acepta todos los Términos y Condiciones, para más información visita: https://www.singlecare.com/es/terminos-y-condiciones. Los nombres, logotipos, marcas y otras marcas comerciales de las farmacias son propiedad exclusiva de sus respectivos dueños.
Los artículos del blog no constituyen asesoramiento médico. Su propósito es brindar información general y no sustituyen el asesoramiento, diagnóstico ni tratamiento médico profesional. Si tiene alguna pregunta sobre una afección médica, consulte siempre a su médico u otro profesional de la salud cualificado. Si cree tener una emergencia médica, llame inmediatamente a su médico o al 911.
© 2026 SingleCare Administrators. Todos los derechos reservados
© 2026 SingleCare Administrators. Todos los derechos reservados